These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29771877)

  • 21. Vaccination strategies for epidemic cholera in Haiti with implications for the developing world.
    Chao DL; Halloran ME; Longini IM
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):7081-5. PubMed ID: 21482756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternative observational designs to estimate the effectiveness of one dose of oral cholera vaccine in Lusaka, Zambia.
    Ferreras E; Blake A; Chewe O; Mwaba J; Zulu G; Poncin M; Rakesh A; Page AL; Quilici ML; Azman AS; Cohuet S; Ciglenecki I; Malama K; Chizema-Kawesha E; Luquero FJ
    Epidemiol Infect; 2020 Mar; 148():e78. PubMed ID: 32167038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacteriological profile of cholera in Tamil Nadu (1980-2001).
    Sundaram SP; Revathi J; Sarkar BL; Bhattacharya SK
    Indian J Med Res; 2002 Dec; 116():258-63. PubMed ID: 12807153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CHOLERA EPIDEMIOLOGY IN ZAMBIA FROM 2000 TO 2010: IMPLICATIONS FOR IMPROVING CHOLERA PREVENTION AND CONTROL STRATEGIES IN THE COUNTRY.
    Olu O; Babaniyi O; Songolo P; Matapo B; Chizema E; Kapin'a-Kanyanga M; Musenga E; Walker O
    East Afr Med J; 2013 Oct; 90(10):324-31. PubMed ID: 26862642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of cholera hotspots in Zambia: A spatiotemporal analysis of cholera data from 2008 to 2017.
    Mwaba J; Debes AK; Shea P; Mukonka V; Chewe O; Chisenga C; Simuyandi M; Kwenda G; Sack D; Chilengi R; Ali M
    PLoS Negl Trop Dis; 2020 Apr; 14(4):e0008227. PubMed ID: 32294084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 2008 cholera epidemic in Zimbabwe: experience of the icddr,b team in the field.
    Ahmed S; Bardhan PK; Iqbal A; Mazumder RN; Khan AI; Islam MS; Siddique AK; Cravioto A
    J Health Popul Nutr; 2011 Oct; 29(5):541-6. PubMed ID: 22106761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a delta ctxA delta zot delta ace derivative of El Tor Ogawa Vibrio cholerae.
    Tacket CO; Losonsky G; Nataro JP; Cryz SJ; Edelman R; Fasano A; Michalski J; Kaper JB; Levine MM
    J Infect Dis; 1993 Dec; 168(6):1536-40. PubMed ID: 8245542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemic cholera in Trujillo, Peru 1992: utility of a clinical case definition and shift in Vibrio cholerae O1 serotype.
    Vugia DJ; Rodriguez M; Vargas R; Ricse C; Ocampo C; Llaque R; Seminario JL; Greene KD; Tauxe RV; Blake PA
    Am J Trop Med Hyg; 1994 May; 50(5):566-9. PubMed ID: 8203704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cholera outbreak in a rural north central Nigerian community: an unmatched case-control study.
    Dan-Nwafor CC; Ogbonna U; Onyiah P; Gidado S; Adebobola B; Nguku P; Nsubuga P
    BMC Public Health; 2019 Jan; 19(1):112. PubMed ID: 30683078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholera outbreak --- Haiti, October 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Nov; 59(43):1411. PubMed ID: 21048563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outbreak of cholera in & around Chandigarh during two successive years (2002, 2003).
    Kaistha N; Mehta M; Gautam V; Gupta V
    Indian J Med Res; 2005 Nov; 122(5):404-7. PubMed ID: 16456254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Euvichol-plus vaccine campaign coverage during the 2017/2018 cholera outbreak in Lusaka district, Zambia: a cross-sectional descriptive study.
    Mukonka VM; Sialubanje C; Matapo BB; Chewe O; Ngomah AM; Ngosa W; Hamoonga R; Sinyange N; Mzyece H; Mazyanga L; Bakyaita N; Kapata N
    BMJ Open; 2023 Oct; 13(10):e070796. PubMed ID: 37798024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology and antibiotic susceptibility of Vibrio cholerae associated with the 2017 outbreak in Kasese district, Uganda.
    Iramiot JS; Rwego IB; Kansiime C; Asiimwe BB
    BMC Public Health; 2019 Oct; 19(1):1405. PubMed ID: 31664972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiologic study of Vibrio cholerae O1 and O139 in Thailand: at the advancing edge of the eighth pandemic.
    Hoge CW; Bodhidatta L; Echeverria P; Deesuwan M; Kitporka P
    Am J Epidemiol; 1996 Feb; 143(3):263-8. PubMed ID: 8561160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru.
    Taylor DN; Cárdenas V; Sanchez JL; Bégué RE; Gilman R; Bautista C; Perez J; Puga R; Gaillour A; Meza R; Echeverria P; Sadoff J
    J Infect Dis; 2000 May; 181(5):1667-73. PubMed ID: 10823767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholera epidemic in Yemen, 2016-18: an analysis of surveillance data.
    Camacho A; Bouhenia M; Alyusfi R; Alkohlani A; Naji MAM; de Radiguès X; Abubakar AM; Almoalmi A; Seguin C; Sagrado MJ; Poncin M; McRae M; Musoke M; Rakesh A; Porten K; Haskew C; Atkins KE; Eggo RM; Azman AS; Broekhuijsen M; Saatcioglu MA; Pezzoli L; Quilici ML; Al-Mesbahy AR; Zagaria N; Luquero FJ
    Lancet Glob Health; 2018 Jun; 6(6):e680-e690. PubMed ID: 29731398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk and Protective Factors for Cholera Deaths during an Urban Outbreak-Lusaka, Zambia, 2017-2018.
    Mutale LS; Winstead AV; Sakubita P; Kapaya F; Nyimbili S; Mulambya NL; Nanzaluka FH; Gama A; Mwale V; Kim S; Ngosa W; Yard E; Sinyange N; Mintz E; Brunkard J; Mukonka V
    Am J Trop Med Hyg; 2020 Mar; 102(3):534-540. PubMed ID: 31933465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "It depends how one understands it:" a qualitative study on differential uptake of oral cholera vaccine in three compounds in Lusaka, Zambia.
    Heyerdahl LW; Pugliese-Garcia M; Nkwemu S; Tembo T; Mwamba C; Demolis R; Chilengi R; Gessner BD; Guillermet E; Sharma A
    BMC Infect Dis; 2019 May; 19(1):421. PubMed ID: 31088376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of V. cholerae O1 biotype El Tor serotype Ogawa possessing the ctxB gene of the classical biotype isolated from well water associated with the cholera outbreak in Kerala, South India.
    Reethy PS; Lalitha KV
    J Water Health; 2021 Jun; 19(3):478-487. PubMed ID: 34152300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Descriptive epidemiology of the cholera outbreak in Zimbabwe 2018-2019: role of multi-sectorial approach in cholera epidemic control.
    Mashe T; Chaibva BV; Nair P; Sani KA; Jallow M; Tarupiwa A; Goredema A; Munyanyi M; Chimusoro A; Mpala N; Masunda KPE; Duri C; Chonzi P; Phiri I
    BMJ Open; 2023 Jan; 13(1):e059134. PubMed ID: 36717140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.